Navigation Links
Amedica Appoints Karl Farnsworth as Chief Financial Officer
Date:3/11/2013

SALT LAKE CITY, March 11, 2013 /PRNewswire/ -- Amedica Corporation, a spinal and reconstructive medical device manufacturer, announced today that Karl Farnsworth has been named Chief Financial Officer (CFO) on February 21, 2013.

Mr. Farnsworth brings more than 25 years of experience as a financial executive for growth-oriented, publicly traded companies in multiple industries. He most recently served as the Senior Vice President and Treasurer with Energy Solutions, Inc. where he led working capital initiatives generating more than $30 million of sustainable cash.

"Karl brings strong, strategic, financial, and management skills coupled with global investment experience to Amedica," said Eric K. Olson , President and Chief Executive Officer, Amedica. "The addition of Karl complements and strengthens our executive management team as we continue to develop innovative products that improve patient outcomes and lower long term healthcare costs."

Prior to joining Amedica, Mr. Farnsworth  served as CFO for Alcan Products Corporation, part of Alcan Inc., which was acquired by Rio Tinto Corporation in 2007. While at Alcan Inc. he spearheaded significant capital investments for the expansion of Alcan's global reach in manufacturing and market penetration into China and Mexico. Also during his tenure at Alcan, he directed a $200 million cash generation initiative throughout Europe and North America.  Additionally, Mr. Farnsworth was appointed and served as a Director on the following corporate boards: Alcan Cable (Canada), Inc.; Stabiloy De (Mexico); EPA Holdings Ltd. (Hong Kong); APC Holding Corporation (USA); and, Alcan (Tianjin) Alloy Products Corporation (China).

Mr. Farnsworth holds a BS in Accounting from Brigham Young University's Marriott School of Management and an MBA in Finance from The Ohio State University, Max Fischer School of Business. Mr. Farnsworth is a licensed Certified Public Accountant (CPA) in Utah, a member of The Ohio Society of CPAs, and is certified in Lean Six Sigma.

About Amedica Corporation:
Amedica is an innovative spine and orthopaedic implant and device marketing, manufacturing, and distribution company that provides advanced implants made from its silicon nitride ceramic technology. The company's platform technology represents a new standard for implants based on superior performance, safety and efficacy. Amedica is a privately held, private equity backed company founded in 1996 by internationally recognized orthopaedic surgeons and ceramicists. The company is ISO 13485 certified, its spine products are FDA cleared, CE marked, and sold in ten countries. Amedica Corporation is based in Salt Lake City, UT.

Media Contact
Stacey Holifield / Stacy Nartker
Schwartz MSL
(781) 684-0770 
Amedica@schwartzmsl.com  


'/>"/>
SOURCE Amedica Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Amedica Names Distinguished Health Care Industry Executive Jay M. Moyes To Board Of Directors
2. Amedica Announces Expansion Of Executive Team
3. Amedica Expands Patent Portfolio with Proprietary Silicon Nitride Total Disc Implant to Treat Neck and Back Pain
4. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
5. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
6. Nephros Appoints John C. Houghton as President and Chief Executive Officer
7. Elsevier Appoints New President of Elsevier CPM Resource Center
8. GenWay Biotech Appoints New Vice President of Custom/OEM
9. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
10. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
11. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017   ... for global supply chains, has published the first annual edition of its ... of more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings ... 2016. ... CSR Risk & Performance Index ...
Breaking Medicine Technology:
(Date:10/12/2017)... Fla. (PRWEB) , ... October 12, 2017 , ... IsoComforter, ... therapy products, announced today the introduction of an innovative new design of the shoulder ... pad so you get maximum comfort while controlling your pain while using cold therapy. ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 ... ... Company, Cal Dining at the University of California Berkeley, and other leading institutions ... leverages the buying power of institutions to change the way animals are raised ...
Breaking Medicine News(10 mins):